---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-062858"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2023-05-22T23:59:59+00:00"
generated_at: "2026-06-14T18:22:57.558734+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elanco shareholders elect two directors despite majority against; stock plans approved

## Summary
- Directors R. David Hoover and Deborah T. Kochevar elected with more against votes than for (125M vs 309M; 164M vs 269M) under plurality.
- Say-on-pay approved with 351M votes for (81% of votes cast, excluding 13.2M broker non-votes).
- Amended and Restated Employee Stock Purchase Plan approved (434M for, 0.6M against).
- Amended and Restated 2018 Stock Plan approved (418M for, 17M against).
- Directors Michael J. Harrington and Kirk P. McDonald elected with strong majorities (260M+ for each).

## SEC filing metadata
- accession: 0001104659-23-062858
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2023-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/tm2316065d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-062858
- JSON: https://secwatch.observer/filing/0001104659-23-062858.json
- Plain text: https://secwatch.observer/filing/0001104659-23-062858.txt

## Key facts
- Shareholder Votes
  Elanco Animal Health Inc shareholders approved Approval of Amended and Restated Elanco Animal Health Incorporated Employee Stock Purchase Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 4. The shareholders approved the Amended and Restated Elanco Animal Health Incorporated Employee Stock Purchase Plan, by the votes set forth in the table below. For Against Abstain Broker Non-Votes 434,472,778 566,174 762,214 13,179,219
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm
- Shareholder Votes
  Elanco Animal Health Inc shareholders approved Non-binding vote on executive compensation.
  - Proposal: say on pay
  - Outcome: passed
  source text: Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco’s named executive officers, by the votes set forth in the table below. For Against Abstain Broker Non-Votes 351,081,265 82,468,671 2,251,230 13,179,219
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm
- Shareholder Votes
  Elanco Animal Health Inc shareholders approved Election of Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Proposal 1. Election of Directors. All of the nominees nominated by the Board for director were elected to serve for a three-year term ending at the 2026 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below. Nominee For Against Abstain Broker Non-Votes Michael J. Harrington 259,613,361 175,243,353 944,452 13,179,219 R. David Hoover 125,220,272 309,651,471 929,423 13,179,219 Deborah T. Kochevar 164,946,577 269,918,338 936,251 13,179,219 Kirk P. McDonald 267,112,564 167,731,710 956,892 13,179,219
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm
- Shareholder Votes
  Elanco Animal Health Inc shareholders approved Approval of Amended and Restated 2018 Elanco Animal Health Incorporated Stock Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 5. The shareholders approved the Amended and Restated 2018 Elanco Animal Health Incorporated Stock Plan, by the votes set forth in the table below. For Against Abstain Broker Non-Votes 417,966,666 17,058,140 776,360 13,179,219
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm
- Shareholder Votes
  Elanco Animal Health Inc shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2023.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco’s independent registered public accounting firm for 2023, by the votes set forth in the table below. For Against Abstain 447,693,969 524,302 762,114
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923062858/0001104659-23-062858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.